SEC Form 4 · accession 0001209191-16-155169
EAGLE PHARMACEUTICALS, INC. · EGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven B Ratoff
Director
Period of report
Apr 3, 2014
Accepted (ET)
Dec 14, 2016 · 4:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827871
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 3, 2014 | P | 3,950 | $12.79 | A | 23,324 | D | |
| Common Stock | Dec 12, 2016 | S | 1,300 | $75.07 | D | 22,024 | D | |
| Common Stock | Dec 13, 2016 | S | 8,700 | $75.00 | D | 13,324 | D |
Table II — derivative securities
No Table II lines on this filing.